Avitar, Inc. Sales Activity Compels Territory Reorganization And Promotion Of Sales Management

December 04, 2000

CANTON, MA, December 4, 2000 – Avitar, Inc. (AMEX: AVR) today announced that in response to recent growth in sales activity they were compelled to reorganize their regional sales teams by dividing the management of their client base into Eastern and Western Areas. The Company has designated two chief sales managers to oversee continued supervision of particular sales regions, to better seize significant market opportunities associated with the expanding distribution of existing and potential clients throughout the Unites States.

"We are very excited to see our client base continue its expansion from sales of the ORALscreen™ product line. To optimize our client relationships and to improve our responsiveness to customer needs, we have engaged in a more effective division of sales territory management responsibility," said Doug Scott, President of Avitar. "Each Area Sales Manager will oversee sales activities of five separate regional sales managers, to better lead our sales force," he added.

Former South Regional Sales Manager, Jeff Burkett has been promoted to the new position of Western Area Sales Manager. He was raised to a heightened level of responsibility after continually proving his ability to create, build and manage a client base with success. He will continue to be based in Dallas-Ft. Worth, Texas.

Len Jonker, formerly Director of Business Development, has been assigned as Eastern Area Sales Manager. He will continue to be based in Grand Rapids, Michigan.

"Len and Jeff have been aggressive in demonstrating their ability to translate the benefits of our patented technology in oral fluid collection into helping organizations set up cost-effective, in-house, drugs-of-abuse testing programs using our ORALscreen product line. This new territory management will improve their ability to lead our sales force as we continue to penetrate the marketplace," said Peter Phildius, CEO and Chief Executive Officer at Avitar.

Avitar, Inc. (AMEX:AVR) headquartered in Canton, Massachusetts, develops, manufactures and markets innovative medical devices based on core technologies in oral fluid diagnostics and customized polyurethane applications. The Company markets a unique portfolio of substance abuse testing products and services that include ORALscreen^TM, the world’s first rapid point-of-contact oral fluid test for drugs of abuse, ORALadvantage^TM, the first comprehensive substance abuse program featuring its oral fluid-based products, HAIRscreen^TM, a laboratory-based test for long term drug abuse using hair, and several other specialized tests for drugs of abuse. ORALscreen is a cost-effective drugs-of-abuse test with potential net cost savings of more than $100.00 per sample tested. Additional products include an oral fluid collection system for DNA testing as well as a proprietary line of polyurethane-based high tech medical devices.

For more information, see Avitar’s website at avitarinc.com.

This release forward looking statements that are subject to risks and uncertainties, including the development and marketing of new applications and other risks that are detailed from time to time in the Company’s filings with the Securities and Exchange Commission.